Publications by authors named "P Schult-Dietrich"

Article Synopsis
  • - The study investigates how hematopoietic stem and progenitor cells (HSPCs) may serve as reservoirs for HIV-1, which complicates finding a cure for the virus.
  • - Experiments showed that various HSPC subpopulations could be infected by HIV-1, mainly through the CXCR4 and CCR5 entry pathways, indicating their vulnerability to the virus.
  • - Analysis of bone marrow samples from HIV-positive individuals revealed the presence of HIV-1 genetic material in some CD34+ cells, supporting the idea that these primitive HSPCs contribute to the HIV-1 reservoir.
View Article and Find Full Text PDF

Background/aims: Middle East respiratory syndrome coronavirus (MERS-CoV) and Marburg virus (MARV) are among the World Health Organization's top 8 emerging pathogens. Both zoonoses share nonspecific early symptoms, a high lethality rate, and a reduced number of specific treatment options. Therefore, we evaluated extracorporeal virus and glycoprotein (GP) elimination by lectin affinity plasmapheresis (LAP).

View Article and Find Full Text PDF

The nucleocapsid protein (NC) is a highly conserved protein in diverse HIV-1 subtypes that plays a central role in virus replication, mainly by interacting with conserved nucleic acid sequences. NC is considered a highly profitable drug target to inhibit multiple steps in the HIV-1 life cycle with just one compound, a unique property not shown by any of the other antiretroviral classes. However, most of NC inhibitors developed so far act through an unspecific and potentially toxic mechanism (zinc ejection) and are mainly being investigated as topical microbicides.

View Article and Find Full Text PDF

The HIV-1 nucleocapsid protein (NC) is considered as an emerging drug target for the therapy of AIDS. Several studies have highlighted the crucial role of NC within the viral replication cycle. However, although NC inhibition has provided in vitro and in vivo antiretroviral activity, drug-candidates which interfere with NC functions are still missing in the therapeutic arsenal against HIV.

View Article and Find Full Text PDF

Cell membrane-anchored (ma) antiviral peptides derived from the C-terminal heptad repeat of the HIV-1 transmembrane glycoprotein gp41 (C-peptides) and expressed from retroviral vectors were shown to efficiently inhibit HIV-1 entry into target cells. Here, we analyzed the influence of the vector backbone, the scaffold modules that anchor the peptide to the membrane and the length of the C-peptide on expression level and antiviral activity. In general, antiviral activity was determined primarily by the density of the C-peptide on the cell surface.

View Article and Find Full Text PDF